Deal Library / Pharma BD Deal Intelligence

King Pharmaceuticals Inc. — Pharma Deals

The Pharma Closeout tracks 3 deals, $4.0B in disclosed deal value, 3 with a post-close Outcome Score for King Pharmaceuticals Inc..

Median Critic Score: 71  ·  Median Outcome Score: 51

Best outcome: King Pharmaceuticals Inc. / Jones Pharma Incorporated (54)  ·  Weakest outcome: King Pharmaceuticals Inc. / Aventis Pharmaceuticals (Intal/Tilade/Synercid rights) (26)

All 3 deals

• King Pharmaceuticals Inc. / Jones Pharma Incorporated — 2000 · $3.4B · Mixed — partial payoff, real shortfalls.
• King Pharmaceuticals Inc. / Bristol-Myers Squibb (Corgard/Corzide/Delestrogen/Florinef rights) — 2001 · $285M · Mixed — partial payoff, real shortfalls.
• King Pharmaceuticals Inc. / Aventis Pharmaceuticals (Intal/Tilade/Synercid rights) — 2002 · $275M · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals